- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04402320
Non Invasive and Invasive Ventilation Post Extubation
25. maj 2020 opdateret af: King Abdul Aziz Specialist Hospital
Comparative Study Between Usage of NIV Versus MV for One Hour After Fulfillment of Weaning Criteria From Ventilation on Re-intubation in Post-traumatic ARDS
Patients and methods: It is a prospective double blind study done on total 300 patients.
Admitted with respiratory failure ARDS due to severe lung contusion.
All of them selected to be ventilated for one week or more.
Patients were randomly allocated in one of three groups each group contain 100 patients.
Group A considered control extubated and follow our routine protocol, patients of group B reconnected to mechanical ventilation before extubation for one hour.
patients of Group C extubated and immediately connected to NIV with BIPAP mode for 1 hour every 12 hours for 24 hours.
Results: There was significant reduction in the number of patients had deterioration in conscious level in all the duration of the study in patients of both groups B and C compared to group A. Also significant reduction in the number of patients had deterioration in clinical parameters of respiration in all the duration of the study in patients of both groups B and C compared to group A as regards high respiratory rate, desaturation and development of hyperdynamic circulation (tachycardia and hypertension).
significant reduction in the number of patients had multiple quadrant parenchymatous infiltration in all the duration of the study in patients of both groups B and C compared to group A. significant reduction in the number of patients had marked limitation to FEV1, FVC and MVV in all the duration of the study in patients of both groups B and C compared to group A. Conclusion: Use of either NIV every 12 hours for 24 hours or MV for one hour after fulfillment of weaning criteria reduces reintubation and post-extubation respiratory failure and decrease the ICU stay in critically ill patients with resolving ARDS due to severe lung trauma.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
It is a prospective double-blind study done on total 300 patients.
Admitted to King Abdulaziz specialist hospital in Taif, KSA.
Between April 2019 and April 2020 with respiratory failure ARDS due to severe lung contusion with these criteria: hypoxic index less than 200, bilateral parenchymatous lung infiltrate, no any acute cardiac insult, failed to maintain SPO2 more than 90% with Non-Invasive Ventilation (NIV) or need of continuous NIV to maintain the previous saturation.
This selected ARDS was due to lung contusion which diagnosed by Computerized tomography of the chest following chest trauma.
All of them selected to be ventilated for one week or more and only those who showed full criteria of weaning from the ventilator enrolled in our study.
Our criteria of weaning include fully conscious patients, hemodynamically stable without any inotropic support, hypoxic index(PAO2/FIO2) more than 200 calculated from the arterial blood gases (ABG), bicarbonate level in arterial blood more than 20 mmol/l, hemoglobin level more than 10 gm%, chest X ray less than one quadrant parenchymatous infiltration in each lung on Murray score of chest Xray, rapid shallow breathing index <105.
Patients were randomly allocated in one of three groups each group contain 100 patients.
Randomization sequence was created using Excel 2007 (Microsoft, Redmond, WA, USA) with a 1:1 allocation using random block sizes of 2 and 4 by an independent doctor.
In this way, sequence generation and type of randomization can be expressed at the same time.
Patients of group A extubated and followed our routine protocol of management post extubation which include Nebulization with Ventolin and epinephrine racemic every 8 hours for 48 hours, chest physical therapy (CPT) every 6 hours for 48 hours include clapping percussion with mechanical vibration and suction plus huffing or coughing and postural drainage if there was atelectasis seen by our routine chest X ray.
Patients of group B reconnected to mechanical ventilation before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use of NIV.
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
300
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Ta'if, Saudi Arabien, 21944
- King abd el Aziz specialist hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 65 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Sandsynlighedsprøve
Studiebefolkning
on total 300 patients.
Admitted to King Abdulaziz specialist hospital in Taif, KSA.
Between April 2019 and April 2020 with respiratory failure ARDS due to severe lung contusion with these criteria: hypoxic index less than 200, bilateral parenchymatous lung infiltrate, no any acute cardiac insult, failed to maintain SPO2 more than 90% with Non-Invasive Ventilation (NIV) or need of continuous NIV to maintain the previous saturation.
This selected ARDS was due to lung contusion which diagnosed by Computerized tomography of the chest following chest trauma.
All of them selected to be ventilated for one week or more and only those who showed full criteria of weaning from the ventilator enrolled in our study
Beskrivelse
Inclusion Criteria:
- respiratory failure ARDS due to severe lung contusion
Exclusion Criteria:
- post arrest, deeply comatosed patients and children below 18 years
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Control group
extubated and weaning from the ventilator and followed our routine protocol of management post extubation without mechanical ventilation or BIPAP machine
|
reconnected to mechanical ventilation before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use
Andre navne:
reconnected to mechanical ventilation before extubation for one hour with sedation
|
|
Invasive ventilation group
reconnected to mechanical ventilator before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use of NIV.
|
reconnected to mechanical ventilation before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use
Andre navne:
reconnected to mechanical ventilation before extubation for one hour with sedation
|
|
non invasive ventilation group
following the same previous protocol done after extubation with immediate connection to NIV with BIPAP mode for 1 hour and repeated every 12hours for 48 hours, BIPAP adjusted in our study by FIO2 40%, PEEP 8 cmH2O, Pressure support of 15 cmH2O.
|
reconnected to mechanical ventilation before extubation for one hour with sedation with midazolam 3-5 milligram/hour intravenous infusion to achieve score 0 or -1on Richmond Agitation - Sedation Scale (RASS).
20 minutes before the end of this hour midazolam infusion discontinued and patients awaked.
Patient put on mechanical ventilation (MV) with the following parameters, FIO2 40%, pressure SIMV mode, PEEP 8 cmH2O, Pressure support 15 cmH2O, Respiratory rate 14/min, Peak inspiratory pressure (PIP) of 35 cmH2O.
Then patients extubated and followed our previous protocol without the use
Andre navne:
reconnected to mechanical ventilation before extubation for one hour with sedation
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
number of patients re-intubated within 48 hours and shorten the duration of ICU stay
Tidsramme: 48 hours
|
monitoring hemodynamics, oxygenation, and conscious level in the studied duration
|
48 hours
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
10. april 2019
Primær færdiggørelse (Faktiske)
2. april 2020
Studieafslutning (Faktiske)
20. april 2020
Datoer for studieregistrering
Først indsendt
20. maj 2020
Først indsendt, der opfyldte QC-kriterier
20. maj 2020
Først opslået (Faktiske)
26. maj 2020
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
27. maj 2020
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
25. maj 2020
Sidst verificeret
1. maj 2020
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Luftvejssygdomme
- Respirationsforstyrrelser
- Tegn og symptomer, luftveje
- Respiratorisk insufficiens
- Hypoxi
- Lægemidlers fysiologiske virkninger
- Neurotransmittermidler
- Molekylære mekanismer for farmakologisk virkning
- Depressive midler til centralnervesystemet
- Bedøvelsesmidler, intravenøst
- Bedøvelsesmidler, general
- Bedøvelsesmidler
- Beroligende midler
- Psykotropiske stoffer
- Hypnotika og beroligende midler
- Adjuvanser, anæstesi
- Anti-angst midler
- GABA modulatorer
- GABA agenter
- Midazolam
Andre undersøgelses-id-numre
- ICU-19-20
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Ingen
IPD-planbeskrivelse
see if both iv or niv after fullfilling the criteria of extubation in ARDS patients can prevent reintubation
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ja
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ja
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Midazolam
-
Diskapi Yildirim Beyazit Education and Research...Ikke rekrutterer endnuPædiatrisk anæstesi | PræmedicineringTyrkiet (Türkiye)
-
SYED HAIDER ALIIkke rekrutterer endnuSedation og Smertebehandling hos Patienter, der Underkaster sig Fleksibel Bronkoskopi
-
Benha UniversityRekrutteringSmertebehandling | Kroniske rygsmerter | Postoperative akutte smerterEgypten
-
University of Tennessee Graduate School of MedicineAfsluttetSedation | VasektomiForenede Stater
-
Seattle Children's HospitalAfsluttet
-
Zhuji People's Hospital of Zhejiang ProvinceAfsluttetKejsersnit | Effektivitet | Sikkerhed | Præeklampsi | MidazolamKina
-
Ganzhou Hemay Pharmaceutical Co., LtdAfsluttet
-
Sohag UniversityIkke rekrutterer endnu
-
Jiangsu HengRui Medicine Co., Ltd.Afsluttet